Provention Bio Reports Third Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Provention Bio Reports Third Quarter 2019 Financial Results

Provention Bio Inc. (PRVB) Tops Q3 EPS by 5c

November 5, 2019 5:00 PM EST

Provention Bio Inc. (NASDAQ: PRVB) reported Q3 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29).

"The PRV-031 program continues to build momentum, with positive developments on the regulatory front that strengthen our confidence in the path forward for the prevention or delay of the onset of clinical type 1 diabetes (T1D) in at-risk individuals," stated Ashleigh Palmer, CEO, Provention Bio. "Recent... More